Skip To Main Content
Daniel Prieto-Alhambra on Muck Rack

Daniel Prieto-Alhambra

As seen in: Emerging Infectious Diseases, Nature, Wiley Online Library, Annals of the Rheumatic Diseases, BMJ Open, British Journal of Sports Medicine, The BMJ, Arthritis Research & Therapy, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational study

|
By Anna Palomar-Cros, James T Brash, Daniel Prieto-Alhambra, Isabella Kaczmarczyk
| The Lancet Verified
Keywords ADHD Observational study Electronic health records Real-world evidence Stimulants Pharmacotherapy Evidence before this study Attention-Deficit Hyperactivity Disorder (ADHD) diagnoses have increased globally over the past few decades, and increase in use of ADHD medications have been reported globally.
Open in Who Shared Issue with article?

Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank - Nature Communications

|
By Daniel Prieto-Alhambra
| Nature Verified
Abstract Long-term sequelae of COVID-19 remain critical public health concerns, with limited therapeutic options available.
Open in Who Shared Issue with article?

Ethnic disparities in COVID-19 mortality and cardiovascular disease in England and Wales between 2020-2022 - Nature Communications

|
By Marta Pineda-Moncusí, Hoda Abbasizanjani, Albert Prats-Uribe, Johan H. Thygesen, Angela Wood, Christopher Tomlinson, Amitava Banerjee, Ashley Akbari, Antonella Delmestri, Laura Coates Verified, Gary Collins, Daniel Prieto-Alhambra, Sara Khalid, Freya Allery
| Nature Verified
Abstract An increased risk of COVID-19 mortality risk among certain ethnic groups is well-reported, however data on ethnic disparities in COVID-19-related cardiovascular disease (CVD)  are lacking. We estimated age-standardised incidence rates and adjusted hazard ratios for 28-day mortality and 30-day CVD by sex for individual ethnicity groups from England and Wales, using linked health and administrative data.
Open in Who Shared Issue with article?
See all 33 licensed articles (40 Total)